In a small clinical trial with TAO patients the intramuscular administration of recombinant vascular endothelial growth factor (VEGF) resulted in the healing of ischemic ulcers and relief of rest pain [6]. This evidence concerns the gene VEGFA and thromboangiitis obliterans.